C-Path Joins Leading Voices and Organizations in Alzheimer’s Research, Drug Discovery and Care to Call for Dramatic New Strategy to Stop Alzheimer’s Disease in Report Out Today Leaders Engaged on Alzheimer’s Disease (LEAD) was created in February 2008 as an open network of Alzheimer’s-serving o
C-Path’s Avilés Discusses Importance of Data Standards in FDA Week Article FDA is encouraging industry to use newly crafted therapeutic data standards — such as utilization of qualified biomarkers
Critical Path Institute and Clinical Data Interchange Standards Consortium Announce Release of Data Standards for Alzheimer’s Disease Research Critical Path Institute(C-Path)and Clinical Data Interchange Standards Consortium(CDISC) today announced the release of version 1.
C-Path’s K. Romero Co-Authors Special Report- Striving for an Integrated Drug-Development Process for Neurodegeneration: the Coalition Against Major Diseases Alzheimer’s and Parkinson’s diseases are the two main neurodegenerative disorders and despite the public health need,
Critical Path Institute Announces Launch of Critical Path Foundation Foundation to foster a global community of philanthropists to improve health and save lives
Pharsight to Work with Critical Path Institute’s Polycystic Kidney Disease Consortium on Disease Progression Modeling Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decisionmaking in
February 8, 2011 Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat
CDISC International Interchange October 12-13 in Baltimore, MD: “Standards for Patients” The CDISC International Interchange this fall in Baltimore will highlight “Standards for Patients”. The Conference on
The Development of a SPSS Data Dictionary and Syntax for Optimizing the Utilization of the Coalition Against Major Diseases (CAMD) AD Clinical Trial Datasets
